company background image
LAB B logo

Genomma Lab Internacional. de BMV:LAB B Stock Report

Last Price

Mex$16.72

Market Cap

Mex$15.9b

7D

2.3%

1Y

18.0%

Updated

21 Jun, 2024

Data

Company Financials +

Genomma Lab Internacional, S.A.B. de C.V.

BMV:LAB B Stock Report

Market Cap: Mex$15.9b

LAB B Stock Overview

Provides pharmaceutical and personal care products primarily in Latin America.

LAB B fundamental analysis
Snowflake Score
Valuation4/6
Future Growth4/6
Past Performance2/6
Financial Health5/6
Dividends3/6

Genomma Lab Internacional, S.A.B. de C.V. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Genomma Lab Internacional. de
Historical stock prices
Current Share PriceMex$16.72
52 Week HighMex$18.77
52 Week LowMex$12.39
Beta0.53
11 Month Change-1.18%
3 Month Change10.80%
1 Year Change18.00%
33 Year Change-18.91%
5 Year Change-4.02%
Change since IPO104.15%

Recent News & Updates

These 4 Measures Indicate That Genomma Lab Internacional. de (BMV:LABB) Is Using Debt Reasonably Well

May 31
These 4 Measures Indicate That Genomma Lab Internacional. de (BMV:LABB) Is Using Debt Reasonably Well

Recent updates

These 4 Measures Indicate That Genomma Lab Internacional. de (BMV:LABB) Is Using Debt Reasonably Well

May 31
These 4 Measures Indicate That Genomma Lab Internacional. de (BMV:LABB) Is Using Debt Reasonably Well

Here's Why Genomma Lab Internacional. de (BMV:LABB) Can Manage Its Debt Responsibly

Jan 29
Here's Why Genomma Lab Internacional. de (BMV:LABB) Can Manage Its Debt Responsibly

Is Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) Trading At A 49% Discount?

Nov 07
Is Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) Trading At A 49% Discount?

Is Genomma Lab Internacional. de (BMV:LABB) Using Too Much Debt?

Mar 31
Is Genomma Lab Internacional. de (BMV:LABB) Using Too Much Debt?

Is Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) Trading At A 32% Discount?

Feb 24
Is Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) Trading At A 32% Discount?

Does Genomma Lab Internacional. de (BMV:LABB) Have A Healthy Balance Sheet?

Dec 07
Does Genomma Lab Internacional. de (BMV:LABB) Have A Healthy Balance Sheet?

Rainbows and Unicorns: Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) Analysts Just Became A Lot More Optimistic

Sep 24
Rainbows and Unicorns: Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) Analysts Just Became A Lot More Optimistic

Analysts Just Made A Major Revision To Their Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) Revenue Forecasts

Aug 01
Analysts Just Made A Major Revision To Their Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) Revenue Forecasts

Genomma Lab Internacional. de (BMV:LABB) Has A Pretty Healthy Balance Sheet

Jul 27
Genomma Lab Internacional. de (BMV:LABB) Has A Pretty Healthy Balance Sheet

Here's Why Genomma Lab Internacional. de (BMV:LABB) Can Manage Its Debt Responsibly

Mar 22
Here's Why Genomma Lab Internacional. de (BMV:LABB) Can Manage Its Debt Responsibly

Are Investors Undervaluing Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) By 44%?

Feb 15
Are Investors Undervaluing Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) By 44%?

Genomma Lab Internacional. de (BMV:LABB) Seems To Use Debt Quite Sensibly

Nov 24
Genomma Lab Internacional. de (BMV:LABB) Seems To Use Debt Quite Sensibly

Here's Why I Think Genomma Lab Internacional. de (BMV:LABB) Is An Interesting Stock

Sep 08
Here's Why I Think Genomma Lab Internacional. de (BMV:LABB) Is An Interesting Stock

Genomma Lab Internacional, S.A.B. de C.V.'s (BMV:LABB) Intrinsic Value Is Potentially 96% Above Its Share Price

Jun 10
Genomma Lab Internacional, S.A.B. de C.V.'s (BMV:LABB) Intrinsic Value Is Potentially 96% Above Its Share Price

Is Genomma Lab Internacional. de (BMV:LABB) A Risky Investment?

May 24
Is Genomma Lab Internacional. de (BMV:LABB) A Risky Investment?

Should You Be Adding Genomma Lab Internacional. de (BMV:LABB) To Your Watchlist Today?

May 06
Should You Be Adding Genomma Lab Internacional. de (BMV:LABB) To Your Watchlist Today?

Investors Who Bought Genomma Lab Internacional. de (BMV:LABB) Shares Five Years Ago Are Now Up 65%

Mar 13
Investors Who Bought Genomma Lab Internacional. de (BMV:LABB) Shares Five Years Ago Are Now Up 65%

Genomma Lab Internacional. de (BMV:LABB) Has A Pretty Healthy Balance Sheet

Feb 19
Genomma Lab Internacional. de (BMV:LABB) Has A Pretty Healthy Balance Sheet

Do Its Financials Have Any Role To Play In Driving Genomma Lab Internacional, S.A.B. de C.V.'s (BMV:LABB) Stock Up Recently?

Feb 02
Do Its Financials Have Any Role To Play In Driving Genomma Lab Internacional, S.A.B. de C.V.'s (BMV:LABB) Stock Up Recently?

Are Investors Undervaluing Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) By 42%?

Jan 15
Are Investors Undervaluing Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) By 42%?

What Is The Ownership Structure Like For Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB)?

Dec 28
What Is The Ownership Structure Like For Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB)?

Genomma Lab Internacional. de (BMV:LABB) Shareholders Have Enjoyed A 54% Share Price Gain

Dec 10
Genomma Lab Internacional. de (BMV:LABB) Shareholders Have Enjoyed A 54% Share Price Gain

Shareholder Returns

LAB BMX PharmaceuticalsMX Market
7D2.3%1.0%0.9%
1Y18.0%-25.5%-1.4%

Return vs Industry: LAB B exceeded the MX Pharmaceuticals industry which returned -25.9% over the past year.

Return vs Market: LAB B exceeded the MX Market which returned -0.9% over the past year.

Price Volatility

Is LAB B's price volatile compared to industry and market?
LAB B volatility
LAB B Average Weekly Movement7.4%
Pharmaceuticals Industry Average Movement4.5%
Market Average Movement4.3%
10% most volatile stocks in MX Market6.7%
10% least volatile stocks in MX Market2.4%

Stable Share Price: LAB B has not had significant price volatility in the past 3 months.

Volatility Over Time: LAB B's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of MX stocks.

About the Company

FoundedEmployeesCEOWebsite
19961,590Juan Marco Sparvieriwww.genommalab.com

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Latin America. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, antacids, anti-ulcers, anti-flu, protection and sexual improvement, treatments against hemorrhoids, against varicose veins, osteoarthritis, ophthalmic medications, and infant nutrition. The company was incorporated in 1996 and is based in Mexico City, Mexico.

Genomma Lab Internacional, S.A.B. de C.V. Fundamentals Summary

How do Genomma Lab Internacional. de's earnings and revenue compare to its market cap?
LAB B fundamental statistics
Market capMex$15.94b
Earnings (TTM)Mex$1.04b
Revenue (TTM)Mex$16.49b

15.1x

P/E Ratio

1.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
LAB B income statement (TTM)
RevenueMex$16.49b
Cost of RevenueMex$6.23b
Gross ProfitMex$10.26b
Other ExpensesMex$9.21b
EarningsMex$1.04b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.11
Gross Margin62.23%
Net Profit Margin6.34%
Debt/Equity Ratio63.7%

How did LAB B perform over the long term?

See historical performance and comparison

Dividends

4.7%

Current Dividend Yield

53%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.